Arkolith/Insider Trading/IGC/Form 4

Moran James P

DirectorIGC Pharma, Inc. (IGC) · full profile →Form 4 · filed Sep 27, 2024
Net Buying
Open-Market Buys
$200K
Open-Market Sells
$0
Net Open-Market Flow
$200K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 25, 2024Buy(P)588K$0.34$200K942K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001185185-24-000924) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML